Related Experiment Video
Updated: Jul 23, 2026

08:04
Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro
Published on: March 18, 2014
Sarcoma therapy: functional outcome and relationship to treatment parameters
K Karasek1, L S Constine, R Rosier
1Dept. of Radiation Oncology, University of Rochester Medical Center, NY.
International Journal of Radiation Oncology, Biology, Physics
|January 1, 1992
Summary
This study found that the volume of tissue irradiated to 55 Gy or more is key for good functional outcomes in sarcoma patients. Doses up to 65 Gy over joints showed minimal morbidity, with a small volume treated to 40 Gy sufficient for good results.
Area of Science:
- Oncology
- Radiation Oncology
- Surgical Oncology
Background:
- Conservative surgery and radiation therapy (RT) are standard for extremity and truncal sarcomas, offering good local control.
- However, the impact of specific surgical techniques and radiation dose distribution on functional outcomes requires further investigation.
Purpose of the Study:
- To systematically evaluate the functional outcomes of patients treated with surgery and RT for sarcomas.
- To correlate functional outcomes with detailed radiation dose distribution and surgical techniques.
Main Methods:
- A functional assessment protocol was developed using a 7-parameter scale (0-3 each) to create an aggregate score.
- Forty-one patients with extremity or truncal sarcomas treated between 1983-1990 underwent functional assessment and dosimetric analysis.
- Interobserver variability was assessed by independent evaluations from an orthopaedic surgeon and radiation oncologist.
Main Results:
- Local control was achieved in 95% of patients, with 83% experiencing good or excellent functional outcomes.
- A positive correlation was found between the volume irradiated to ≥55 Gy and functional score, strength, fibrosis, and skin changes.
- Radiation doses up to 65 Gy, even over joint spaces, did not significantly impact range of motion or total functional score.
Conclusions:
- A validated functional assessment system provides detailed insights into patient outcomes after combined modality sarcoma therapy.
- Radiation doses up to 65 Gy, including over joints, are well-tolerated.
- The volume of tissue irradiated to ≥55 Gy is the most critical factor influencing functional outcomes, while sparing a small volume (<40 Gy) is sufficient for good results.
Related Concept Videos
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

